Ovarian Tumors

What are ovarian tumors?

Ovarian tumors can form in infants and adolescents born female on one or both ovaries, the organs that store and release eggs and produce female hormones. Ovarian masses may be cysts or tumors. Tumors can be cancerous or benign, both tumors and cysts may appear individually or in clusters.

Ovarian tumors account for one percent of all malignant tumors found in children between birth and age 17. In females younger than 8, four out of five ovarian tumors are benign.

Ovarian tumors are distinguished from ovarian cysts because they are a more solid mass of tissue, while cysts are filled with fluid, tissues, or other materials. Some ovarian cysts can develop into cancer. Non-functional cysts, which do not go away on their own and are not associated with a woman producing an egg each month, can develop to be malignant.

How we care for ovarian tumors

 Malignant ovarian tumors are treated at Dana-Farber/Boston Children's through our Solid Tumor Center. Our treatment team includes medical oncologists, surgical oncologists, radiation oncologists, and pediatric subspecialists, including gynecologists, who have specialized expertise in treating ovarian tumors.

In children and adolescents, ovarian tumors have a much higher cure rate than adult forms of ovarian cancer. At Dana-Farber/Boston Children's, almost all ovaries are saved when removing ovarian tumors, helping to preserve your future fertility.

If the ovarian tumor is benign, it will be treated through the Gynecology Program at Boston Children’s Hospital.

Our areas of research for ovarian tumors

Many ovarian tumors are a type of germ cell tumor. Various germ cell tumor research studies are underway to help build our understanding of how treatment types and dosages can be modified according to the tumor sub-type, stage, location on the body, and the age and gender of the child to provide the best possible outcome.

Due to the rarity of germ cell tumors in children statistically meaningful data with multivariate analysis is difficult to achieve. To address that, the Malignant Germ Cell International Collaborative (MaGIC) was formed. This consortium, led by A. Lindsay Frazier, MD, a pediatric oncologist at Dana-Farber/Boston Children’s, is a collaboration of the world’s experts in germ cell tumors, including pediatric, gynecologic, and genito-urinary oncologists.

Clinical trials for ovarian tumors

For many children with rare or hard-to-treat conditions, including testicular germ cell tumors, clinical trials – research studies evaluating new treatment approaches – provide new options.

Participation in any clinical trial is completely voluntary. We will take care to fully explain all elements of the treatment plan prior to the start of the trial, and you may remove your child from the medical study at any time.